Jörgen Thielmann
Director/Board Member at BIOFRONTERA AG
Network origin in Jörgen Thielmann first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jörgen Thielmann via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BIOFRONTERA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Chairman | |
Delphi Unternehmensberatung AG
 Delphi Unternehmensberatung AG Financial ConglomeratesFinance Delphi Unternehmensberatung AG provides investment services. The private company is based in Heidelberg, Germany. | Financial Conglomerates | Corporate Officer/Principal Chairman | |
| 4BASEBIO PLC | Biotechnology | Chief Executive Officer Director/Board Member | |
| SPARTA AG | Investment Managers | Chairman Director/Board Member | |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Agos Consulting | Founder | ||
Genetrix SL
 Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Chief Executive Officer | |
| University of Giessen | College/University | Undergraduate Degree | |
Biofrontera Pharma GmbH
 Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Miscellaneous Commercial Services | Chief Executive Officer | |
Vaxdyn SL
 Vaxdyn SL BiotechnologyHealth Technology Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain. | Biotechnology | Director/Board Member | |
| Epidesease SL | Director/Board Member | ||
| BIOTECHNOLOGY ASSETS, S.A. | Biotechnology | Chief Executive Officer | |
Indical Bioscience GmbH
 Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Antibióticos de León SLU
 Antibióticos de León SLU Pharmaceuticals: MajorHealth Technology Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain. | Pharmaceuticals: Major | Chief Executive Officer | |
| Universität zu Köln | College/University | Doctorate Degree | |
| Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
Araclon Biotech SL
 Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain. | Miscellaneous Commercial Services | Chief Executive Officer | |
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
| I2i Capital Ltd. | Director/Board Member | ||
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| 4basebio Slu | Director/Board Member | ||
| 4basebio Discovery Ltd. | Director/Board Member | ||
Kither Biotech Srl
 Kither Biotech Srl Pharmaceuticals: MajorHealth Technology Kither Biotech Srl is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on the treatment of chronic inflammatory diseases. The company was founded by Emilio Hirsch, Marco Kevin Malisani, and Alberto Bardelli and is headquartered in Turin, Italy. | Pharmaceuticals: Major | Director/Board Member | |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Wholesale Distributors | Director/Board Member | |
| Ghent University | College/University | Graduate Degree | |
tesa Labtec GmbH
 tesa Labtec GmbH Pharmaceuticals: MajorHealth Technology Part of AdhexPharma SAS, tesa Labtec GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Langenfeld, Germany. The company was founded in 1990 by Günter Cordes. The CEO is Detlev Radloff. tesa Labtec was acquired by AdhexPharma SAS from maxingvest AG on September 30, 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
Sophos Technology GmbH
 Sophos Technology GmbH Internet Software/ServicesTechnology Services Sophos Technology GmbH engages in the development and marketing of information technology security and mobile communication solutions. It develops professional cloud-based short message service and alert platforms. The company was founded by Jan Hichert, Markus Hennig, and Gert Hansen in 2000 and is headquartered in Karlsruhe, Germany. | Internet Software/Services | Director of Finance/CFO | |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Founder | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
| UNITED INTERNET AG | Internet Software/Services | Director/Board Member | |
| THYSSENKRUPP NUCERA AG & CO. KGAA | Engineering & Construction | Director/Board Member | |
| MGI - MEDIA AND GAMES INVEST SE | Packaged Software | Director/Board Member | |
| Ruhr-Universität Bochum | College/University | Doctorate Degree | |
thyssenkrupp Steel Europe AG
 thyssenkrupp Steel Europe AG SteelNon-Energy Minerals thyssenkrupp Steel Europe AG manufactures carbon steel, stainless steel, and special steel materials. Its products include hot and precision strips, heavy plates, sheet and coated products, organic coated strips and sheets, composite materials, electrical steel products, tinplates and black plates, and medium-wide strips. The company was founded in 1997 and is headquartered in Duisburg, Germany. | Steel | Corporate Officer/Principal | |
| THYSSENKRUPP AG | Steel | Corporate Officer/Principal | |
| Fachhochschule für Oekonomie & Management | College/University | Corporate Officer/Principal | |
| Rhine Waal University of Applied Sciences | College/University | Corporate Officer/Principal | |
| University of Münster | College/University | Undergraduate Degree | |
National Bank AG
 National Bank AG Major BanksFinance National Bank AG provides commercial, investment, mortgage, and retail banking services. The firm offers a wide range of financing facilities including bank-to-bank facilities, export-project-financing, buyer's credits, guarantees, forfeiting and confirmations of Letters of Credit. The company was founded in 1921 and is headquartered in Essen, Germany. | Major Banks | Director/Board Member | |
| Hochschule Worms | College/University | Undergraduate Degree | |
| Lergenmüller Gruppe | Director of Finance/CFO | ||
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Biotechnology | Chief Executive Officer | |
| Stüfe & Partner Vermögensverwaltung oHG | Corporate Officer/Principal |
Statistics
International
| Germany | 29 |
| Spain | 10 |
| United Kingdom | 7 |
| Italy | 3 |
| United States | 2 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 4 |
Operational
| Director/Board Member | 68 |
| Corporate Officer/Principal | 23 |
| Chairman | 17 |
| Chief Executive Officer | 16 |
| Undergraduate Degree | 10 |
Most connected contacts
| Insiders | |
|---|---|
| Heikki Lanckriet | 17 |
| Karin Lergenmüller | 15 |
| Helge Lubenow | 14 |
| María del Pilar de la Huerta Martínez | 13 |
| Franca Ruhwedel | 13 |
| Ulrich Granzer | 12 |
| Kevin Weber | 11 |
| Karlheinz Schmelig | 11 |
| John Borer | 10 |
| Wilhelm Konrad Zours | 10 |
| Ludwig Lutter | 7 |
| Pamela Keck | 7 |
| Reinhard Eyring | 4 |
| Jürgen Christian Baumann | 3 |
| Anke zur Muehlen | 1 |
- Stock Market
- Insiders
- Jörgen Thielmann
- Company connections
